An Italian study published in Nature Medicine provides compelling evidence that fecal microbiota transplantation (FMT) can enhance the effectiveness of immunotherapy in patients with advanced metastatic renal cell carcinoma (mRCC).
University of British Columbia researchers have engineered gut bacteria that dim their fluorescent glow in the presence of illness. Their findings could improve how we diagnose problems in the gut by using bacteria that already live there. The work appears in Cell.
A Japanese research team has discovered a new compound that can advance the body’s internal clock—offering hope for faster recovery from jet lag and better adaptation to night-shift work.
Baylor College of Medicine researchers are part of a collaborative research group with AstraZeneca and Memorial Sloan Kettering Cancer Center that have identified 22 genes which increase the risk of developing a range of chronic conditions following a common viral infection.
New research reveals how Parkinson’s spreads from the gut to the brain, with the help of immune cells—offering a new potential therapeutic strategy—in a study in mice led by scientists at the UK Dementia Research Institute at UCL (University College London).
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in the Nature Medicine journal.
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it’s needed is here to improve the precision and comfort of cancer therapy.
Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR system.
Large study of patients in U.S., Colombia, Nigeria and India finds symptom burden highest in high-income countries
Olympus today announced the U.S. launch of its most advanced single-use fine needle biopsy device.